In vivo non-invasive monitoring of dystrophin correction in a new Duchenne muscular dystrophy reporter mouse
Duchenne muscular dystrophy (DMD) is a fatal genetic disorder caused by mutations in the
dystrophin gene. To enable the non-invasive analysis of DMD gene correction strategies in …
dystrophin gene. To enable the non-invasive analysis of DMD gene correction strategies in …
Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy
L Amoasii, JCW Hildyard, H Li, E Sanchez-Ortiz… - Science, 2018 - science.org
Mutations in the gene encoding dystrophin, a protein that maintains muscle integrity and
function, cause Duchenne muscular dystrophy (DMD). The deltaE50-MD dog model of DMD …
function, cause Duchenne muscular dystrophy (DMD). The deltaE50-MD dog model of DMD …
Precise correction of Duchenne muscular dystrophy exon deletion mutations by base and prime editing
F Chemello, AC Chai, H Li, C Rodriguez-Caycedo… - Science …, 2021 - science.org
Duchenne muscular dystrophy (DMD) is a fatal muscle disease caused by the lack of
dystrophin, which maintains muscle membrane integrity. We used an adenine base editor …
dystrophin, which maintains muscle membrane integrity. We used an adenine base editor …
Prevention of muscular dystrophy in mice by CRISPR/Cas9–mediated editing of germline DNA
C Long, JR McAnally, JM Shelton, AA Mireault… - Science, 2014 - science.org
Duchenne muscular dystrophy (DMD) is an inherited X-linked disease caused by mutations
in the gene encoding dystrophin, a protein required for muscle fiber integrity. DMD is …
in the gene encoding dystrophin, a protein required for muscle fiber integrity. DMD is …
CRISPR/Cas9-mediated genome editing corrects dystrophin mutation in skeletal muscle stem cells in a mouse model of muscle dystrophy
Muscle stem cells (MuSCs) hold great therapeutic potential for muscle genetic disorders,
such as Duchenne muscular dystrophy (DMD). The CRISP/Cas9-based genome editing is a …
such as Duchenne muscular dystrophy (DMD). The CRISP/Cas9-based genome editing is a …
[HTML][HTML] Cellular reprogramming, genome editing, and alternative CRISPR Cas9 technologies for precise gene therapy of Duchenne muscular dystrophy
In the past decade, the development of two innovative technologies, namely, induced
pluripotent stem cells (iPSCs) and the CRISPR Cas9 system, has enabled researchers to …
pluripotent stem cells (iPSCs) and the CRISPR Cas9 system, has enabled researchers to …
Single-swap editing for the correction of common Duchenne muscular dystrophy mutations
Duchenne muscular dystrophy (DMD) is a fatal X-linked recessive disease of progressive
muscle weakness and wasting caused by the absence of dystrophin protein. Current gene …
muscle weakness and wasting caused by the absence of dystrophin protein. Current gene …
CRISPR correction of Duchenne muscular dystrophy
The ability to efficiently modify the genome using CRISPR technology has rapidly
revolutionized biology and genetics and will soon transform medicine. Duchenne muscular …
revolutionized biology and genetics and will soon transform medicine. Duchenne muscular …
Adenoviral vectors encoding CRISPR/Cas9 multiplexes rescue dystrophin synthesis in unselected populations of DMD muscle cells
I Maggio, J Liu, JM Janssen, X Chen… - Scientific reports, 2016 - nature.com
Mutations disrupting the reading frame of the~ 2.4 Mb dystrophin-encoding DMD gene
cause a fatal X-linked muscle-wasting disorder called Duchenne muscular dystrophy (DMD) …
cause a fatal X-linked muscle-wasting disorder called Duchenne muscular dystrophy (DMD) …
Efficient restoration of the dystrophin gene reading frame and protein structure in DMD myoblasts using the CinDel method
JP Iyombe-Engembe, DL Ouellet, X Barbeau… - … Therapy-Nucleic Acids, 2016 - cell.com
The CRISPR/Cas9 system is a great revolution in biology. This technology allows the
modification of genes in vitro and in vivo in a wide variety of living organisms. In most …
modification of genes in vitro and in vivo in a wide variety of living organisms. In most …